Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring.

Olivia Keiser 1, * Hannock Tweya 1 Andrew Boulle 1 Paula Braitstein 1 Mauro Schechter 1 Martin Brinkhof 1 François Dabis 1 Suely Tuboi 1 Eduardo Sprinz 1 Mar Pujades-Rodriguez 1 Alexandra Calmy 1 Nagalingeswaran Kumarasamy 1 Denis Nash 1 Andreas Jahn 1 Patrick Macphail 1 Ruedi Lüthy 1 Robin Wood 1 Matthias Egger 1
* Auteur correspondant
1 Desmond Tutu HIV Centre
Abstract : BACKGROUND: In high-income countries, viral load is routinely measured to detect failure of antiretroviral therapy (ART) and guide switching to second-line ART. Viral load monitoring is not generally available in resource-limited settings. We examined switching from nonnucleoside reverse transcriptase inhibitor (NNRTI)-based first-line regimens to protease inhibitor-based regimens in Africa, South America and Asia. DESIGN AND METHODS: Multicohort study of 17 ART programmes. All sites monitored CD4 cell count and had access to second-line ART and 10 sites monitored viral load. We compared times to switching, CD4 cell counts at switching and obtained adjusted hazard ratios for switching (aHRs) with 95% confidence intervals (CIs) from random-effects Weibull models. RESULTS: A total of 20 113 patients, including 6369 (31.7%) patients from 10 programmes with access to viral load monitoring, were analysed; 576 patients (2.9%) switched. Low CD4 cell counts at ART initiation were associated with switching in all programmes. Median time to switching was 16.3 months [interquartile range (IQR) 10.1-26.6] in programmes with viral load monitoring and 21.8 months (IQR 14.0-21.8) in programmes without viral load monitoring (P < 0.001). Median CD4 cell counts at switching were 161 cells/microl (IQR 77-265) in programmes with viral load monitoring and 102 cells/microl (44-181) in programmes without viral load monitoring (P < 0.001). Switching was more common in programmes with viral load monitoring during months 7-18 after starting ART (aHR 1.38; 95% CI 0.97-1.98), similar during months 19-30 (aHR 0.97; 95% CI 0.58-1.60) and less common during months 31-42 (aHR 0.29; 95% CI 0.11-0.79). CONCLUSION: In resource-limited settings, switching to second-line regimens tends to occur earlier and at higher CD4 cell counts in ART programmes with viral load monitoring compared with programmes without viral load monitoring.
Type de document :
Article dans une revue
AIDS, Lippincott, Williams & Wilkins, 2009, 23 (14), pp.1867-74. 〈10.1097/QAD.0b013e32832e05b2〉
Liste complète des métadonnées

Littérature citée [12 références]  Voir  Masquer  Télécharger
http://www.hal.inserm.fr/inserm-00385651
Contributeur : Evelyne Mouillet <>
Soumis le : jeudi 23 septembre 2010 - 09:54:46
Dernière modification le : mercredi 29 novembre 2017 - 09:51:19
Document(s) archivé(s) le : vendredi 24 décembre 2010 - 02:26:52

Fichiers

inserm-00385651_edited.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Olivia Keiser, Hannock Tweya, Andrew Boulle, Paula Braitstein, Mauro Schechter, et al.. Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring.. AIDS, Lippincott, Williams & Wilkins, 2009, 23 (14), pp.1867-74. 〈10.1097/QAD.0b013e32832e05b2〉. 〈inserm-00385651〉

Exporter

BibTeX TEI DC DCterms EndNote

Partager

Métriques

Consultations de la notice

146

Téléchargements de fichiers

468

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD